Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5397319 [patent_doc_number] => 20090317382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'USE OF EFFECTOR-FUNCTION-DEFICIENT ANTIBODIES FOR TREATMENT OF AUTO-IMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/096196 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37086 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317382.pdf [firstpage_image] =>[orig_patent_app_number] => 12096196 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/096196
Use of effector-function-deficient antibodies for treatment of auto-immune diseases Dec 14, 2006 Issued
Array ( [id] => 5159409 [patent_doc_number] => 20070172453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Tolerogenic approach for type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 11/606637 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15856 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172453.pdf [firstpage_image] =>[orig_patent_app_number] => 11606637 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/606637
Tolerogenic approach for type 1 diabetes Nov 29, 2006 Abandoned
Array ( [id] => 5177053 [patent_doc_number] => 20070178113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Superantigen conjugate' [patent_app_type] => utility [patent_app_number] => 11/604057 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13502 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178113.pdf [firstpage_image] =>[orig_patent_app_number] => 11604057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/604057
Superantigen conjugate Nov 21, 2006 Abandoned
Array ( [id] => 4976841 [patent_doc_number] => 20070218072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'METHODS OF IMPROVING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS' [patent_app_type] => utility [patent_app_number] => 11/562174 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 39650 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218072.pdf [firstpage_image] =>[orig_patent_app_number] => 11562174 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/562174
METHODS OF IMPROVING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Nov 20, 2006 Abandoned
Array ( [id] => 5215627 [patent_doc_number] => 20070104708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Compositions, methods, and kits relating to resistin' [patent_app_type] => utility [patent_app_number] => 11/590736 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 40347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104708.pdf [firstpage_image] =>[orig_patent_app_number] => 11590736 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/590736
Compositions, methods, and kits relating to resistin Oct 30, 2006 Abandoned
Array ( [id] => 5040250 [patent_doc_number] => 20070092532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Arthritis vaccines and methods' [patent_app_type] => utility [patent_app_number] => 11/586346 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8454 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092532.pdf [firstpage_image] =>[orig_patent_app_number] => 11586346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/586346
Arthritis vaccines and methods Oct 24, 2006 Abandoned
Array ( [id] => 6574306 [patent_doc_number] => 20100129344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'MEDICAL USES AND THERAPIES BASED UPON THE ACTION OF AZUROCIDIN ON IGFBP-1' [patent_app_type] => utility [patent_app_number] => 12/091004 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16986 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129344.pdf [firstpage_image] =>[orig_patent_app_number] => 12091004 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/091004
MEDICAL USES AND THERAPIES BASED UPON THE ACTION OF AZUROCIDIN ON IGFBP-1 Oct 18, 2006 Abandoned
Array ( [id] => 6595440 [patent_doc_number] => 20100062471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Biomarkers for Multiple Sclerosis and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/088228 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 53537 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062471.pdf [firstpage_image] =>[orig_patent_app_number] => 12088228 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/088228
Biomarkers for Multiple Sclerosis and Methods of Use Thereof Sep 28, 2006 Abandoned
Array ( [id] => 5178027 [patent_doc_number] => 20070179087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/534782 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16713 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179087.pdf [firstpage_image] =>[orig_patent_app_number] => 11534782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/534782
METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS Sep 24, 2006 Abandoned
Array ( [id] => 5465110 [patent_doc_number] => 20090325310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Innovativer TSH-R-Ab-Kit' [patent_app_type] => utility [patent_app_number] => 11/992563 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11992563 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992563
Innovative TSH-R-Ab-kit Sep 24, 2006 Issued
Array ( [id] => 5074823 [patent_doc_number] => 20070014798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Antibodies to dendritc cells and human dendritic cell populations and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/524875 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 25313 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014798.pdf [firstpage_image] =>[orig_patent_app_number] => 11524875 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/524875
Antibodies to dendritc cells and human dendritic cell populations and uses thereof Sep 21, 2006 Abandoned
Array ( [id] => 5465684 [patent_doc_number] => 20090325884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis' [patent_app_type] => utility [patent_app_number] => 11/990227 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6319 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325884.pdf [firstpage_image] =>[orig_patent_app_number] => 11990227 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/990227
Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis Aug 9, 2006 Abandoned
Array ( [id] => 5415867 [patent_doc_number] => 20090041754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHOD FOR IDENTIFYING TARGET PROTEIN OF DRUG AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR DIABETES USING THE TARGET PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/909031 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31735 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041754.pdf [firstpage_image] =>[orig_patent_app_number] => 11909031 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909031
Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein Aug 8, 2006 Issued
Array ( [id] => 8421931 [patent_doc_number] => 08278420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Composition and method for prevention and treatment of type I diabetes' [patent_app_type] => utility [patent_app_number] => 11/997996 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28928 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11997996 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/997996
Composition and method for prevention and treatment of type I diabetes Aug 3, 2006 Issued
Array ( [id] => 5068944 [patent_doc_number] => 20070190045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity' [patent_app_type] => utility [patent_app_number] => 11/498381 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20885 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190045.pdf [firstpage_image] =>[orig_patent_app_number] => 11498381 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498381
Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity Aug 2, 2006 Abandoned
Array ( [id] => 5343262 [patent_doc_number] => 20090181912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 11/996776 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18009 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181912.pdf [firstpage_image] =>[orig_patent_app_number] => 11996776 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996776
GLP/1/exendin 4 IgG Fc fusion constructs for treatment of diabetes Jul 26, 2006 Issued
Array ( [id] => 5204984 [patent_doc_number] => 20070026465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period' [patent_app_type] => utility [patent_app_number] => 11/492645 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6659 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026465.pdf [firstpage_image] =>[orig_patent_app_number] => 11492645 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/492645
Method for detecting GAD65 autoreactive T cells newly diagnosed type1 diabetic patients and in the prediabetic period Jul 24, 2006 Abandoned
Array ( [id] => 5533046 [patent_doc_number] => 20090232834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Methods and Agents to Treat Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 11/989011 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8801 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232834.pdf [firstpage_image] =>[orig_patent_app_number] => 11989011 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/989011
Methods and Agents to Treat Autoimmune Diseases Jul 17, 2006 Abandoned
Array ( [id] => 5264899 [patent_doc_number] => 20090117584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Non-Human mammalian Arthritis Model Featuring Human Antibodies Against Citrul-Linated Proteins' [patent_app_type] => utility [patent_app_number] => 11/922990 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5231 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117584.pdf [firstpage_image] =>[orig_patent_app_number] => 11922990 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/922990
Non-Human mammalian Arthritis Model Featuring Human Antibodies Against Citrul-Linated Proteins Jun 28, 2006 Abandoned
Array ( [id] => 5602273 [patent_doc_number] => 20060292618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance' [patent_app_type] => utility [patent_app_number] => 11/474162 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23344 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292618.pdf [firstpage_image] =>[orig_patent_app_number] => 11474162 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/474162
Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance Jun 22, 2006 Abandoned
Menu